These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 3352680)

  • 1. Disturbing dreams with long-acting verapamil.
    Kumar KL; Hodges M
    N Engl J Med; 1988 Apr; 318(14):929-30. PubMed ID: 3352680
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-acting verapamil and heart failure.
    Mohindra SK; Udeani GO
    JAMA; 1989 Feb; 261(7):994. PubMed ID: 2915424
    [No Abstract]   [Full Text] [Related]  

  • 3. Securon SR: sustained-release verapamil.
    Drug Ther Bull; 1987 Jun; 25(12):47-8. PubMed ID: 3608822
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemical injury of the oral mucosa from verapamil.
    Guttenberg SA
    N Engl J Med; 1990 Aug; 323(9):615. PubMed ID: 2381453
    [No Abstract]   [Full Text] [Related]  

  • 5. Verapamil for hypertension.
    Med Lett Drugs Ther; 1987 Apr; 29(737):37-8. PubMed ID: 3561323
    [No Abstract]   [Full Text] [Related]  

  • 6. [The toxicity of slow-release verapamil and chronic kidney disease].
    Huelmos A; Alegría E; Vázquez C
    Rev Esp Cardiol; 1994 Nov; 47(11):780. PubMed ID: 7800911
    [No Abstract]   [Full Text] [Related]  

  • 7. [Verapamil-associated liver injury].
    Odeh M; Oliven A
    Harefuah; 1998 Jan; 134(1):36-7. PubMed ID: 9517278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified release verapamil induced cardiogenic shock.
    Nanda U; Ashish A; Why HJ
    Emerg Med J; 2005 Nov; 22(11):832-3. PubMed ID: 16244356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new sustained-release formulation of verapamil in the treatment of hypertension.
    Midtbo KA; Hals O; Lauve O
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):125S-132S. PubMed ID: 3540222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Slow-release verapamil and hyperglycemic metabolic acidosis.
    Roth A; Miller HI; Belhassen B; Laniado S
    Ann Intern Med; 1989 Jan; 110(2):171-2. PubMed ID: 2909215
    [No Abstract]   [Full Text] [Related]  

  • 11. Sustained release verapamil workshop. Tarrytown, New York, 17 January 1985.
    Br J Clin Pract Suppl; 1985 Jun; 42():1-55. PubMed ID: 3929823
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antihypertensive action of verapamil. Results with a new delayed-action form for once-daily administration].
    Pozenel H
    Fortschr Med; 1985 Jun; 103(23):639-42. PubMed ID: 4018698
    [No Abstract]   [Full Text] [Related]  

  • 13. An unusual case of nightmares with galantamine.
    Iraqi A; Hughes TL
    J Am Geriatr Soc; 2009 Mar; 57(3):565. PubMed ID: 19278402
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of sustained release verapamil and hydrochlorothiazide in hypertension--effect on blood pressure and metabolic variables.
    Lehtonen A; Gordin A; Salo H
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):301-5. PubMed ID: 3623734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of controlled-onset extended-release verapamil in middle-aged and older patients with hypertension and coronary artery disease.
    White WB; Johnson MF; Anders RJ; Elliott WJ; Black HR
    Am Heart J; 2001 Dec; 142(6):1010-5. PubMed ID: 11717605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of a slow-release formulation of verapamil.
    Taylor SH
    Br J Clin Pract Suppl; 1985 Jun; 42():34. PubMed ID: 3929826
    [No Abstract]   [Full Text] [Related]  

  • 17. The bioavailability of a slow-release verapamil formulation.
    Norris RJ; Muirhead DC; Christie RB; Devane JG; Bottini PB
    Br J Clin Pract Suppl; 1985 Jun; 42():9-16. PubMed ID: 3929828
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evaluation of the efficacy of verapamil in slow-release preparations in the treatment of stable exertion angina].
    Scrutinio D; Lagioia R; De Toma L; Mangini S; Accettura D; De Nicolò M
    Cardiologia; 1982 Oct; 27(10):963-71. PubMed ID: 6927458
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effectiveness and tolerance of combined verapamil retard and hydrochlorothiazide. Results of a double-blind, randomized study].
    von Manteuffel GE; Rakette S; Woll EM; Reinfrank J; Schiemann J
    Fortschr Med; 1995 Sep; 113(26):374-8. PubMed ID: 7498858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma concentrations of S-verapamil after single doses of two different galenic formulations of racemic verapamil.
    Harder S; Siewert M; Thürmann P; Blume H; Rietbrock N; Siewert B
    Arzneimittelforschung; 1993 May; 43(5):520-2. PubMed ID: 8328995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.